Multiomics Approach Distinguishes SPTBN4 as a Key Molecule in Diagnosis, Prognosis, and Immune Suppression of Testicular Seminomas.

Jianfeng Xiang, Yanjie Xiang, Qintao Ge, Yunhong Zhou, Hailiang Zhang, Wenhao Xu, Shifang Zhou, Liang Chen

Abstract read

In one paragraph

Article in International journal of genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jianfeng XiangDepartment of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Yanjie XiangCenter for Reproductive Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Qintao GeDepartment of Urology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0001-5040-6699

Yunhong ZhouDepartment of Radiology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.

Hailiang ZhangDepartment of Urology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.

Wenhao XuDepartment of Urology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0002-0660-9162

Shifang ZhouDepartment of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0001-9346-9905

Liang ChenInterventional Department, Shanghai Jiao Tong University Affiliated Sixth People's Hospital South Campus (Shanghai Fengxian District Central Hospital), Shanghai, China.ORCID https://orcid.org/0009-0003-4705-7178

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immune suppressionmultiomics analysisprognostic biomarkersingle-cell RNA sequencingSPTBN4testicular seminomastumor microenvironment

Identifiers

PMID40321316

DOI10.1155/ijog/3530098

PMCPMC12048191

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.